Picard Medical Inc
PMI2.265USD
-0.065-2.79%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
166.93MMarket Cap
LossP/E TTM
More Details of Picard Medical Inc Company
Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
Picard Medical Inc Info
Ticker SymbolPMI
Company namePicard Medical Inc
IPO dateAug 29, 2025
CEOSchnegelsberg (Patrick N.J)
Number of employees75
Security typeOrdinary Share
Fiscal year-endAug 29
Address1992 E. Silverlake Rd.
CityTUCSON
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code85713
Phone15203080796
Website
Ticker SymbolPMI
IPO dateAug 29, 2025
CEOSchnegelsberg (Patrick N.J)
Company Executives of Picard Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Chris Hsieh
Mr. Chris Hsieh
Director
Director
--
--
Mr. Sam Van
Mr. Sam Van
Independent Director
Independent Director
--
--
Mr. George Ye
Mr. George Ye
Independent Director
Independent Director
--
--
Mr. Patrick N.J. Schnegelsberg
Mr. Patrick N.J. Schnegelsberg
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bernard Skaggs
Mr. Bernard Skaggs
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Matt Schuster
Mr. Matt Schuster
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Richard G. Smith
Mr. Richard G. Smith
Scientific Advisor, SynCardia
Scientific Advisor, SynCardia
--
--
Mr. Richard A. Fang, Ph.D.
Mr. Richard A. Fang, Ph.D.
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Chris Hsieh
Mr. Chris Hsieh
Director
Director
--
--
Mr. Sam Van
Mr. Sam Van
Independent Director
Independent Director
--
--
Mr. George Ye
Mr. George Ye
Independent Director
Independent Director
--
--
Mr. Patrick N.J. Schnegelsberg
Mr. Patrick N.J. Schnegelsberg
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bernard Skaggs
Mr. Bernard Skaggs
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Matt Schuster
Mr. Matt Schuster
Chief Operating Officer
Chief Operating Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2023
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
1.85M
87.10%
Europe
281.00K
13.23%
Rest of the world
-7.00K
-0.33%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hunniwell Picard I LLC
53.76%
Sindex SSI Financing LLC
10.78%
HRT Financial LP
0.33%
Citadel Advisors LLC
0.28%
Centiva Capital, LP
0.06%
Other
34.80%
Shareholders
Shareholders
Proportion
Hunniwell Picard I LLC
53.76%
Sindex SSI Financing LLC
10.78%
HRT Financial LP
0.33%
Citadel Advisors LLC
0.28%
Centiva Capital, LP
0.06%
Other
34.80%
Shareholder Types
Shareholders
Proportion
Corporation
64.53%
Hedge Fund
0.35%
Investment Advisor
0.35%
Venture Capital
0.02%
Other
34.74%
Institutional Shareholding
Updated: Fri, Sep 12
Updated: Fri, Sep 12
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
2
47.56M
65.76%
+47.56M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hunniwell Picard I LLC
39.62M
53.76%
--
--
Sep 26, 2025
Sindex SSI Financing LLC
7.94M
10.78%
--
--
Sep 26, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Picard Medical Inc?
The top five shareholders of Picard Medical Inc are:
Hunniwell Picard I LLC holds 39.62M shares, accounting for 53.76% of the total shares.
Sindex SSI Financing LLC holds 7.94M shares, accounting for 10.78% of the total shares.
Hunniwell Picard I LLC holds 39.62M shares, accounting for 53.76% of the total shares.
Sindex SSI Financing LLC holds 7.94M shares, accounting for 10.78% of the total shares.
What are the top three shareholder types of Picard Medical Inc?
The top three shareholder types of Picard Medical Inc are:
Hunniwell Picard I LLC
Sindex SSI Financing LLC
HRT Financial LP
Hunniwell Picard I LLC
Sindex SSI Financing LLC
HRT Financial LP
How many institutions hold shares of Picard Medical Inc (PMI)?
As of 2025Q3, 2 institutions hold shares of Picard Medical Inc, with a combined market value of approximately 47.56M, accounting for 65.76% of the total shares. Compared to --, institutional shareholding has increased by --.
What is the biggest source of revenue for Picard Medical Inc?
In FY2025Q2, the -- business generated the highest revenue for Picard Medical Inc, amounting to -- and accounting for --% of total revenue.
